Atlas Trials

Use of Ventavis in Patients With Postembolic Residual Pulmonary Hypertension

Clinical trial NCT02238535 · UNKNOWN

Trial details

NCT number
NCT02238535
Sponsor
Meshalkin Research Institute of Pathology of Circulation
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Residual Pulmonary Hypertension
Start date
2014-09-01
Primary completion
2016-03-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.